Pattern hair loss — where DHT-blockers and follicle-supporting peptides are the main tools.
Male and female pattern hair loss is driven largely by DHT's effect on follicles, which is why 5-alpha-reductase inhibitors (finasteride, dutasteride) are the evidence-based core. Copper peptides like AHK-Cu and GHK-Cu are explored for follicle and scalp microcirculation support.
The DHT-blockers have real evidence and real side-effect considerations worth discussing with a prescriber. The peptides are adjuncts with lighter evidence. This is educational context, not a prescription.
Ranked by editorial relevance — a measure of how central each compound is to the conversation, not a claim of effectiveness.
| Compound | Type | Why it's relevant |
|---|---|---|
| Finasteride | supplement | 5-alpha-reductase inhibitor; evidence-based DHT blocker. |
| Dutasteride | supplement | More potent dual 5-AR inhibitor. |
| AHK-Cu | peptide | Copper peptide; follicle/microcirculation interest. |
| GHK-Cu | peptide | Copper peptide; scalp and skin support. |